Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women.

Ziller M, Herwig J, Ziller V, Kauka A, Kostev K, Hadji P.

Gynecol Endocrinol. 2012 Dec;28(12):1002-5. doi: 10.3109/09513590.2012.705369. Epub 2012 Jul 26.

PMID:
22835159
[PubMed - indexed for MEDLINE]
2.

[Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].

Schnabel M, Eser G, Ziller V, Mann D, Mann E, Hadji P.

Zentralbl Chir. 2005 Oct;130(5):469-75. German.

PMID:
16220445
[PubMed - indexed for MEDLINE]
4.

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ.

N Engl J Med. 1998 Feb 19;338(8):485-92.

PMID:
9443925
[PubMed - indexed for MEDLINE]
Free Article
5.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
[PubMed - indexed for MEDLINE]
6.

A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

Thiébaud D, Bigler JM, Renteria S, Pache T, Welti HJ, Landry M, Burckhardt P.

Climacteric. 1998 Sep;1(3):202-10.

PMID:
11907945
[PubMed - indexed for MEDLINE]
7.

Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.

Ongphiphadhanakul B, Piaseu N, Tung SS, Chailurkit L, Rajatanavin R.

Maturitas. 2000 Feb 15;34(2):179-84.

PMID:
10714913
[PubMed - indexed for MEDLINE]
8.

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.

McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH 3rd, Ensrud KE, Burdeska A, Mills T; Oral Ibandronate Study Group.

J Bone Miner Res. 2004 Jan;19(1):11-8.

PMID:
14753731
[PubMed - indexed for MEDLINE]
9.

Breast cancer and bone mineral density: the Marburg Breast Cancer and Osteoporosis Trial (MABOT II).

Kalder M, Jäger C, Seker-Pektas B, Dinas K, Kyvernitakis I, Hadji P.

Climacteric. 2011 Jun;14(3):352-61. doi: 10.3109/13697137.2011.557754. Epub 2011 Mar 17.

PMID:
21413864
[PubMed - indexed for MEDLINE]
10.

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.

Prelevic GM, Bartram C, Wood J, Okolo S, Ginsburg J.

Gynecol Endocrinol. 1996 Dec;10(6):413-20.

PMID:
9032569
[PubMed - indexed for MEDLINE]
11.

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A.

Ann Intern Med. 2002 Dec 3;137(11):875-83.

PMID:
12458987
[PubMed - indexed for MEDLINE]
12.

[Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].

Insua A, Negri A, Zanchetta JR.

Medicina (B Aires). 1995;55(5 Pt 1):408-14. Spanish.

PMID:
8728770
[PubMed - indexed for MEDLINE]
13.

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

JAMA. 2002 May 22-29;287(20):2668-76.

PMID:
12020302
[PubMed - indexed for MEDLINE]
14.

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

Mirkin S, Komm BS, Pan K, Chines AA.

Climacteric. 2013 Jun;16(3):338-46. doi: 10.3109/13697137.2012.717994. Epub 2012 Oct 5.

PMID:
23038989
[PubMed - indexed for MEDLINE]
15.

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR.

Arch Intern Med. 2000 Jul 24;160(14):2161-6.

PMID:
10904459
[PubMed - indexed for MEDLINE]
16.

Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.

Martyn-St James M, Carroll S.

Bone. 2008 Sep;43(3):521-31. doi: 10.1016/j.bone.2008.05.012. Epub 2008 May 26.

PMID:
18602880
[PubMed - indexed for MEDLINE]
17.

Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.

Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G.

Fertil Steril. 2009 Sep;92(3):1045-52. doi: 10.1016/j.fertnstert.2009.02.093. Epub 2009 Jul 26.

PMID:
19635616
[PubMed - indexed for MEDLINE]
18.

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.

Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

Osteoporos Int. 2005 Apr;16(4):372-9. Epub 2005 Jan 15.

PMID:
15654581
[PubMed - indexed for MEDLINE]
19.

Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.

Camozzi V, Lumachi F, Mantero F, Piccolo M, Luisetto G.

Osteoporos Int. 2003 Jul;14(7):602-8. Epub 2003 Apr 29.

PMID:
12730752
[PubMed - indexed for MEDLINE]
20.

The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.

Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W, Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, Wu Q, Zhao SJ.

Osteoporos Int. 2012 Apr;23(4):1317-27. doi: 10.1007/s00198-011-1577-2. Epub 2011 Apr 20.

PMID:
21505910
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk